Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors [Phase 1, Phase 2]
Early-phase clinical trial evaluating haploidentical transplant with NK cell infusion for pediatric leukemia and solid tumors; study termina…
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer [Phase 1]
A Phase 1 trial of fenretinide in patients with refractory or relapsed hematologic cancers has been completed, investigating safety across m…
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen [Phase 1, Phase 2]
A Phase 1/2 trial evaluating allogeneic hematopoietic cell transplantation using a busulfan-based conditioning regimen across multiple hemat…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating busulfan, fludarabine, and total-body irradiation as conditioning for donor stem cell transplantation …
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant [Phase 2]
This Phase 2 trial evaluated sirolimus, tacrolimus, and antithymocyte globulin to prevent graft-versus-host disease in patients with hematol…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease [Phase 2]
Phase 2 trial update describing donor umbilical cord blood transplantation for advanced hematologic cancers, including leukemia, lymphoma, m…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies [NA]
Clinical trial update for fludarabine-based conditioning prior to allogeneic transplantation in advanced hematologic malignancies; study com…
-
CLINICAL_TRIALS trial_result · 2017-06-07Clinical Trial Update: Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR [NA]
A completed clinical trial investigates improving adherence to oral cancer agents and self-care of symptoms using an IVR system, sponsored b…
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT [Phase 2]
Phase 2 trial of sirolimus and mycophenolate mofetil as graft-versus-host disease prophylaxis in myeloablative, matched related donor hemato…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease [Phase 2]
Phase 2 trial evaluating reduced-intensity conditioning with busulfan and fludarabine, with or without antithymocyte globulin, followed by d…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases [Phase 2]
Phase 2 study evaluating T-cell depletion and donor hematopoietic stem cell transplantation with T-cell infusions in patients with various h…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Zinc Supplements in Lowering Cadmium Levels in Smokers [Phase 2]
Phase 2 clinical trial evaluated zinc supplementation to lower cadmium levels in smokers; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases [NA]
This ClinicalTrials.gov update reports on a completed study evaluating whether music can reduce anxiety and pain in adults undergoing bone m…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating conditioning with alemtuzumab, busulfan, and cyclophosphamide followed by donor stem cell transplantatio…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases [Phase 2]
Phase 2 trial evaluating donor peripheral stem cell transplant and donor natural killer cell transplant after conditioning with total-body i…
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: Lenalidomide in Patients With Chronic Lymphocytic Leukemia Older Than 65 Years of Age [Phase 2]
Phase 2 clinical trial evaluating lenalidomide in older patients with chronic lymphocytic leukemia. The study results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Study of Bone Marrow Samples From Patients With Acute Leukemia
Completed clinical trial evaluating bone marrow samples from patients with acute leukemia.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant [Phase 3]
A Phase 3 trial of moxifloxacin to prevent bacterial infections in patients who have undergone a donor stem cell transplant was terminated.
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers [Phase 2]
Phase 2 trial assessing donor peripheral stem cell transplant with fludarabine and busulfan in hematologic cancers has completed; results po…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Amplification and Selection of Antimicrobial Resistance in the Intestine
This update reports the completion of a clinical trial studying amplification and selection of antimicrobial resistance in the intestine, fo…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies [Phase 1]
Phase 1 clinical trial update investigating cord blood fucosylation to enhance homing and engraftment in patients with hematologic malignanc…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: FOB in HSCT and Leukemia Patients With Acute Respiratory Symptoms and Pulmonary Infiltrates [NA]
Clinical trial NCT01328873 reports completed results for FOB in hematopoietic stem cell transplant and leukemia patients with acute respirat…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Hematological Malignancies [Phase 1]
This document reports the completion of a Phase 1 safety and pharmacology study of SNX-5422 in patients with refractory hematologic malignan…
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients
Completed trial evaluating rasburicase for chemotherapy- or malignancy-induced hyperuricemia in leukemia and lymphoma patients.
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant [Phase 1]
A Phase 1 trial evaluating rasburicase to prevent graft-versus-host disease in patients undergoing donor stem cell transplantation; the stud…